SCHEMBL24858840

SCHEMBL24858840

Cc1ccc2c3c4c5ccccc5n(-c5ccccc5)c4ccc3n(-c3ccccc3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ ATM Q13315 1/20 0.53
▸ FGFR1 P11362 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ BRCA1 P38398 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ GFER P55789 1/20 0.38
▸ RXFP1 Q9HBX9 2/20 0.38
▸ MAPK8 P45983 1/20 0.38
▸ HPGD P15428 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ HTT P42858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19342647 0.95 KDM4E (0.44) KDM4EL3MBTL1ATMFGFR1ALDH1A1
SCHEMBL20412020 0.94 KDM4E (0.44) KDM4EL3MBTL1ATMFGFR1ALDH1A1
SCHEMBL17472239 0.92 KDM4E (0.55) KDM4EL3MBTL1ATMFGFR1ALDH1A1
SCHEMBL883474 0.90 KDM4E (0.67) KDM4EL3MBTL1ATMFGFR1ALDH1A1
SCHEMBL10206196 0.90 KDM4E (0.50) KDM4EL3MBTL1ATMFGFR1ALDH1A1
SCHEMBL10206157 0.90 KDM4E (0.50) KDM4EL3MBTL1ATMFGFR1ALDH1A1
SCHEMBL14325131 0.89 KDM4E (0.52) KDM4EL3MBTL1ATMFGFR1ALDH1A1
SCHEMBL15451793 0.88 KDM4E (0.59) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL20412007 0.87 KDM4E (0.47) KDM4EL3MBTL1ATMFGFR1ALDH1A1
SCHEMBL18416313 0.87 L3MBTL1 (0.53) KDM4EL3MBTL1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765968-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-09-19 — — US disclosed
US-20230122208-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-04-20 — — US disclosed
US-11548905-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-01-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230122208-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ZYX, SLC39A3, SOD3 KDM4E 1688/4885L3MBTL1 155/4885ATM 3316/4885
US-11548905-B2 Organic electroluminescent materials and devices ZYX, SLC39A3, SOD3 KDM4E 1688/4885L3MBTL1 155/4885ATM 3316/4885
US-11765968-B2 Organic electroluminescent materials and devices TPR, TPO, DDT KDM4E 1874/4885L3MBTL1 541/4885ATM 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback